UHPLC is fast becoming mainstream in many laboratories. With increased data, however, comes a directly proportional increase in data integration.
Ultra high performance liquid chromatography (UHPLC) technology is fast becoming mainstream in many laboratories. There are many compelling reasons for this switch, such as the speed of analysis, low solvent usage and significantly shorter runtimes resulting in many more samples being analysed.
With increased data, however, comes a directly proportional increase in data integration. Ensuring the accuracy and appropriateness of data integration is essential because it is used for all subsequent calculations, such as calibrations, determining the purity of drug substances and analysis of unknowns.
Optimizing a chromatogram’s integration continues to be a time-consuming task, even for the most experienced chromatographer and an area of significant resource drain for laboratories. It is mostly performed using a chromatographic data system (CDS) but while different software packages provide the means for the analyst to apply peak specific instructions to optimize integration, the process often involves trial and error methods or manual integration to determine the correct integration for each peak. Integration is also subjective and laboratories have different criteria and treatments. For example, not all chromatographers adopt the same approach when there are unresolved peak groups. Some might apply the valley-to-valley approach while others require exponential skim or a combination of these options.
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.